Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells

Xi Huang, Jisen Dai, Jeanine Fournier, Aktar M. Ali, Qi Zhang, Krystyna Frenkel

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Ferrous ion (Fe2+) is long thought to be the most likely active species, producing oxidants through interaction of Fe2+ with oxygen (O2). Because current iron overload therapy uses only Fe3+ chelators, such as desferrioxamine (DFO), we have tested a hypothesis that addition of a Fe2+ chelator, 2,2′-dipyridyl (DP), may be more efficient and effective in preventing iron-induced oxidative damage in human liver HepG2 cells than DFO alone. Using ferrozine as an assay for iron measurement, levels of cellular iron in HepG2 cells treated with iron compounds correlated well with the extent of lipid peroxidation (r = 0.99 after log transformation). DP or DFO alone decreased levels of iron and lipid peroxidation in cells treated with iron. DFO + DP together had the most significant effect in preventing cells from lipid peroxidation but not as effective in decreasing overall iron levels in the cells. Using ESR spin trapping technique, we further tested factors that can affect oxidant-producing activity of Fe2+ with dissolved O2 in a cell-free system. Oxidant formation enhanced with increasing Fe2+ concentrations and reached a maximum at 5 mM of Fe2+. When the concentration of Fe2+ was increased to 50 mM, the oxidant-producing activity of Fe2+ sharply decreased to zero. The initial ratio of Fe3+:Fe2+ did not affect the oxidant producing activity of Fe2+. However, an acidic pH (< 3.5) significantly slowed down the rate of the reaction. Our results suggest that reaction of Fe2+ with O2 is an important one for oxidant formation in biological system, and therefore, drugs capable of inhibiting redox activity of Fe2+ should be considered in combination with a Fe3+ chelator for iron overload chelation therapy.

Original languageEnglish (US)
Pages (from-to)84-92
Number of pages9
JournalFree Radical Biology and Medicine
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2002

Fingerprint

Hep G2 Cells
Chelation
Oxidants
Liver
Deferoxamine
Iron
Ions
Chelating Agents
Lipid Peroxidation
Iron Overload
Ferrozine
Lipids
Iron Compounds
Chelation Therapy
Spin Trapping
Cell-Free System
Oxidation-Reduction
Biological systems
Oxygen
Paramagnetic resonance

Keywords

  • Free radicals
  • Iron autoxidation
  • Iron chelators
  • Iron overload

ASJC Scopus subject areas

  • Medicine(all)
  • Toxicology
  • Clinical Biochemistry

Cite this

Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. / Huang, Xi; Dai, Jisen; Fournier, Jeanine; Ali, Aktar M.; Zhang, Qi; Frenkel, Krystyna.

In: Free Radical Biology and Medicine, Vol. 32, No. 1, 01.01.2002, p. 84-92.

Research output: Contribution to journalArticle

Huang, Xi ; Dai, Jisen ; Fournier, Jeanine ; Ali, Aktar M. ; Zhang, Qi ; Frenkel, Krystyna. / Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. In: Free Radical Biology and Medicine. 2002 ; Vol. 32, No. 1. pp. 84-92.
@article{f90f6f94bbda4e8fa4ed9fef086fffae,
title = "Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells",
abstract = "Ferrous ion (Fe2+) is long thought to be the most likely active species, producing oxidants through interaction of Fe2+ with oxygen (O2). Because current iron overload therapy uses only Fe3+ chelators, such as desferrioxamine (DFO), we have tested a hypothesis that addition of a Fe2+ chelator, 2,2′-dipyridyl (DP), may be more efficient and effective in preventing iron-induced oxidative damage in human liver HepG2 cells than DFO alone. Using ferrozine as an assay for iron measurement, levels of cellular iron in HepG2 cells treated with iron compounds correlated well with the extent of lipid peroxidation (r = 0.99 after log transformation). DP or DFO alone decreased levels of iron and lipid peroxidation in cells treated with iron. DFO + DP together had the most significant effect in preventing cells from lipid peroxidation but not as effective in decreasing overall iron levels in the cells. Using ESR spin trapping technique, we further tested factors that can affect oxidant-producing activity of Fe2+ with dissolved O2 in a cell-free system. Oxidant formation enhanced with increasing Fe2+ concentrations and reached a maximum at 5 mM of Fe2+. When the concentration of Fe2+ was increased to 50 mM, the oxidant-producing activity of Fe2+ sharply decreased to zero. The initial ratio of Fe3+:Fe2+ did not affect the oxidant producing activity of Fe2+. However, an acidic pH (< 3.5) significantly slowed down the rate of the reaction. Our results suggest that reaction of Fe2+ with O2 is an important one for oxidant formation in biological system, and therefore, drugs capable of inhibiting redox activity of Fe2+ should be considered in combination with a Fe3+ chelator for iron overload chelation therapy.",
keywords = "Free radicals, Iron autoxidation, Iron chelators, Iron overload",
author = "Xi Huang and Jisen Dai and Jeanine Fournier and Ali, {Aktar M.} and Qi Zhang and Krystyna Frenkel",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0891-5849(01)00770-5",
language = "English (US)",
volume = "32",
pages = "84--92",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells

AU - Huang, Xi

AU - Dai, Jisen

AU - Fournier, Jeanine

AU - Ali, Aktar M.

AU - Zhang, Qi

AU - Frenkel, Krystyna

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Ferrous ion (Fe2+) is long thought to be the most likely active species, producing oxidants through interaction of Fe2+ with oxygen (O2). Because current iron overload therapy uses only Fe3+ chelators, such as desferrioxamine (DFO), we have tested a hypothesis that addition of a Fe2+ chelator, 2,2′-dipyridyl (DP), may be more efficient and effective in preventing iron-induced oxidative damage in human liver HepG2 cells than DFO alone. Using ferrozine as an assay for iron measurement, levels of cellular iron in HepG2 cells treated with iron compounds correlated well with the extent of lipid peroxidation (r = 0.99 after log transformation). DP or DFO alone decreased levels of iron and lipid peroxidation in cells treated with iron. DFO + DP together had the most significant effect in preventing cells from lipid peroxidation but not as effective in decreasing overall iron levels in the cells. Using ESR spin trapping technique, we further tested factors that can affect oxidant-producing activity of Fe2+ with dissolved O2 in a cell-free system. Oxidant formation enhanced with increasing Fe2+ concentrations and reached a maximum at 5 mM of Fe2+. When the concentration of Fe2+ was increased to 50 mM, the oxidant-producing activity of Fe2+ sharply decreased to zero. The initial ratio of Fe3+:Fe2+ did not affect the oxidant producing activity of Fe2+. However, an acidic pH (< 3.5) significantly slowed down the rate of the reaction. Our results suggest that reaction of Fe2+ with O2 is an important one for oxidant formation in biological system, and therefore, drugs capable of inhibiting redox activity of Fe2+ should be considered in combination with a Fe3+ chelator for iron overload chelation therapy.

AB - Ferrous ion (Fe2+) is long thought to be the most likely active species, producing oxidants through interaction of Fe2+ with oxygen (O2). Because current iron overload therapy uses only Fe3+ chelators, such as desferrioxamine (DFO), we have tested a hypothesis that addition of a Fe2+ chelator, 2,2′-dipyridyl (DP), may be more efficient and effective in preventing iron-induced oxidative damage in human liver HepG2 cells than DFO alone. Using ferrozine as an assay for iron measurement, levels of cellular iron in HepG2 cells treated with iron compounds correlated well with the extent of lipid peroxidation (r = 0.99 after log transformation). DP or DFO alone decreased levels of iron and lipid peroxidation in cells treated with iron. DFO + DP together had the most significant effect in preventing cells from lipid peroxidation but not as effective in decreasing overall iron levels in the cells. Using ESR spin trapping technique, we further tested factors that can affect oxidant-producing activity of Fe2+ with dissolved O2 in a cell-free system. Oxidant formation enhanced with increasing Fe2+ concentrations and reached a maximum at 5 mM of Fe2+. When the concentration of Fe2+ was increased to 50 mM, the oxidant-producing activity of Fe2+ sharply decreased to zero. The initial ratio of Fe3+:Fe2+ did not affect the oxidant producing activity of Fe2+. However, an acidic pH (< 3.5) significantly slowed down the rate of the reaction. Our results suggest that reaction of Fe2+ with O2 is an important one for oxidant formation in biological system, and therefore, drugs capable of inhibiting redox activity of Fe2+ should be considered in combination with a Fe3+ chelator for iron overload chelation therapy.

KW - Free radicals

KW - Iron autoxidation

KW - Iron chelators

KW - Iron overload

UR - http://www.scopus.com/inward/record.url?scp=0036138979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036138979&partnerID=8YFLogxK

U2 - 10.1016/S0891-5849(01)00770-5

DO - 10.1016/S0891-5849(01)00770-5

M3 - Article

C2 - 11755320

AN - SCOPUS:0036138979

VL - 32

SP - 84

EP - 92

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 1

ER -